Ombrabulin hydrochloride

CAS No. 253426-24-3

Ombrabulin hydrochloride ( AVE-8062;AVE-8062A;AC-7700 )

Catalog No. M13754 CAS No. 253426-24-3

A novel combretastatin A-4 derivative that strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 588 Get Quote
50MG 1764 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ombrabulin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel combretastatin A-4 derivative that strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organ.
  • Description
    A novel combretastatin A-4 derivative that strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organ; a vascular-disrupting agent.Ovarian Cancer Phase 2 Clinical
  • Synonyms
    AVE-8062;AVE-8062A;AC-7700
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Cancer
  • Indication
    Ovarian Cancer

Chemical Information

  • CAS Number
    253426-24-3
  • Formula Weight
    438.90
  • Molecular Formula
    C21H27ClN2O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO; Methanol: ≥ 30 mg/mL
  • SMILES
    O=C(NC1=CC(/C=C\C2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC)[C@@H](N)CO.[H]Cl
  • Chemical Name
    Propanamide, 2-amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-, hydrochloride (1:1), (2S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hori K, et al. Br J Cancer. 2002 May 20;86(10):1604-14.
2. Kim TJ, et al. Cancer Res. 2007 Oct 1;67(19):9337-45.
3. Sessa C, et al. Clin Cancer Res. 2013 Sep 1;19(17):4832-42.
molnova catalog
related products
  • Albiglutide TFA (782...

    Albiglutide TFA, a glucagon-like peptide (GLP)-1 mimetic, is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).

  • Jatrorrhizine chlori...

    Jatrorrhizine chloride is a potent and orally active uptake-2 transporter inhibitor. It exhibits a critical neuroprotective role in H2O2-induced apoptosis via inhibition of the MAPK pathway in HT22 hippocampal neurons.

  • Antalarmin hydrochlo...

    CRF1 antagonist